At the IGTP TODAY

News

- Projects, Research

DATOS-CAT Project: Integration and Analysis of Biomedical Databases

The collaborative action DATOS-CAT aims to enhance the visibility and scientific impact of population-based cohorts created in Catalonia. Additionally, it seeks to enrich the procedures used in these cohorts, promoting their applicability in other similar contexts. To achieve this, it focuses on improving data interoperability, thereby facilitating their exploitation and use in scientific research.

- Campus Can Ruti, Research

Screening high-risk groups for tuberculosis in low-incidence countries: a cost-effective strategy

A study led by researchers from IGTP, in collaboration with health economics experts from Can Ruti, UPF, and Agència de Salut Pública de Barcelona, offers new recommendations for optimising tuberculosis screening programmes in low-incidence countries. Published in the journal Eurosurveillance, this work reviews various studies to determine if these programmes targeting higher-risk groups are economically effective.

- Research

A boost to biomedical research with statistical tools: from COVID-19 analysis to data management with REDCapDM

IGTP’s Biostatistics Unit have recently published two notable articles. The first paper, appearing in Scientific Reports, reveals the role of socioeconomic inequalities and vaccination in the spread of the pandemic. The second, published in BMC Medical Research Methodology, introduces REDCapDM, a new R package designed to enhance efficiency and reliability in the management of research data collected through the popular REDCap platform.

- Innovation, Research

Progress in developing specific immunotherapies for type 1 diabetes

Researchers from IGTP and Ahead Therapeutics have been exploring a treatment based on liposome-type nanoparticles to address the autoimmunity of type 1 diabetes for years. A study recently published in the Journal of Autoimmunity examines the response of macrophages to this immunotherapy, serving as a preliminary step before clinical trials.